USMLE Step 1 & 2 Common Dermatologic Conditions
Last updated: May 2, 2026
Common Dermatologic Conditions questions are one of the highest-leverage areas to study for the USMLE Step 1 & 2. This guide breaks down the rule, the elements you need to recognize, the named traps that catch most students, and a memory aid that scales to test day. Read it once, then practice the same sub-topic adaptively in the app.
The rule
Most USMLE dermatology items are solved by matching three features: lesion morphology (macule, papule, plaque, vesicle, pustule, nodule), distribution (extensor vs flexural, photodistributed, dermatomal, intertriginous), and a single defining clue (Auspitz sign, Nikolsky sign, herald patch, target lesion, honey crust). When morphology + distribution + clue line up, the diagnosis is forced and the question collapses to either mechanism or next-best-step. Treat the answer choices as a differential of close mimics and eliminate based on the clue the vignette emphasized.
Elements breakdown
Psoriasis vulgaris
Chronic T-cell driven hyperproliferative dermatosis with characteristic scale.
- well-demarcated erythematous plaques with silvery scale
- extensor surfaces, scalp, umbilicus, gluteal cleft
- Auspitz sign — pinpoint bleeding when scale removed
- nail pitting, oil spots, onycholysis
- associated psoriatic arthritis, uveitis
Common examples:
- plaque psoriasis on elbows and knees
- guttate psoriasis after streptococcal pharyngitis
Atopic dermatitis (eczema)
Chronic relapsing pruritic dermatitis tied to filaggrin loss-of-function and Th2 skew.
- pruritic, ill-defined erythematous patches
- flexural surfaces in older children and adults
- facial and extensor involvement in infants
- atopic triad — asthma, allergic rhinitis, eczema
- lichenification from chronic scratching
Pityriasis rosea
Self-limited eruption associated with HHV-6/7 reactivation.
- herald patch precedes generalized eruption by 1–2 weeks
- oval salmon-colored papulosquamous lesions
- Christmas-tree distribution along skin tension lines on trunk
- spares face, palms, soles
- resolves spontaneously over 6–8 weeks
Tinea (dermatophyte infection)
Superficial fungal infection by Trichophyton, Microsporum, Epidermophyton.
- annular plaque with raised scaly border, central clearing
- KOH prep shows septate branching hyphae
- Wood lamp fluorescence with Microsporum (some strains)
- named by site — corporis, cruris, pedis, capitis
- topical azole or terbinafine; oral for capitis or onychomycosis
Seborrheic dermatitis
Inflammatory response to Malassezia yeast in sebaceous areas.
- greasy yellow scale on erythematous base
- scalp, eyebrows, nasolabial folds, retroauricular
- worsened by Parkinson disease and HIV
- treated with ketoconazole shampoo, low-potency topical steroid
Acne vulgaris
Pilosebaceous unit disorder driven by Cutibacterium acnes, androgens, and follicular hyperkeratinization.
- comedones (open and closed), papules, pustules, nodules
- face, chest, upper back
- topical retinoid + benzoyl peroxide first line
- oral isotretinoin for nodulocystic — pregnancy category X, lipid and LFT monitoring
Contact dermatitis
Type IV hypersensitivity (allergic) or direct irritant injury.
- geometric or linear distribution following exposure
- vesicles and weeping in acute phase
- common triggers — nickel, urushiol, fragrances, neomycin
- patch testing identifies allergen
Bullous pemphigoid vs pemphigus vulgaris
Autoimmune blistering — distinguished by depth and antigen target.
- pemphigoid — tense bullae, elderly, anti-hemidesmosome (BP180/230), Nikolsky negative
- pemphigus — flaccid bullae, mucosal involvement, anti-desmoglein 1/3, Nikolsky positive
- DIF — pemphigoid linear at BMZ, pemphigus net-like intercellular
Erythema multiforme / SJS / TEN spectrum
Mucocutaneous reaction — EM often infectious (HSV, Mycoplasma), SJS/TEN drug-induced.
- target lesions on palms and soles in EM
- mucosal erosions and skin sloughing in SJS/TEN
- SJS <10% BSA, TEN >30% BSA
- high-risk drugs — sulfonamides, allopurinol, lamotrigine, anticonvulsants
- stop offending drug, supportive care in burn unit
Bacterial pyodermas
Superficial Staph aureus and Strep pyogenes skin infections.
- impetigo — honey-colored crust, periorificial in children
- cellulitis — warm, tender, ill-defined erythema
- erysipelas — sharply demarcated, raised, often facial
- necrotizing fasciitis — pain out of proportion, crepitus, rapid spread
Common patterns and traps
The Defining-Clue Lock
USMLE dermatology vignettes almost always plant a single signature finding that uniquely identifies the disease — Auspitz sign, Nikolsky sign, herald patch, target lesions, honey crust, dermatomal vesicles. When you see the clue, the diagnosis is locked and you should ignore distractors that fit the morphology but not the clue. The trap is when two diseases share morphology and the clue is the only differentiator.
A wrong choice that fits the general lesion description (e.g., 'eczema' for a scaly plaque) but cannot account for the named clue (the silvery scale that bleeds when removed).
The Close-Mimic Differential
Distractors are engineered as the disease most often confused with the right answer at the bedside — pemphigoid is offered against pemphigus, seborrheic dermatitis against scalp psoriasis, tinea corporis against nummular eczema, rosacea against lupus. Recognizing which mimic each distractor represents is the core skill.
Bullous pemphigoid offered as a distractor in a vignette that explicitly says 'mucosal erosions' and 'flaccid bullae that extend with lateral pressure.'
Wrong Treatment for the Right Disease
The diagnosis is obvious; the trap is in the management arm. Topical steroid for tinea (causes tinea incognito), oral antibiotics for viral exanthem, systemic steroid for HSV mistaken as eczema herpeticum, topical steroid alone for pemphigus.
A choice offering high-potency topical steroid for an annular scaly lesion the vignette identifies with KOH-positive hyphae.
The Drug-Reaction Bait
A vignette gives a recent drug exposure (sulfonamide, allopurinol, lamotrigine, anticonvulsant) and a rash, then offers diagnoses that are not drug reactions or asks for next step in management. The correct first move is almost always to stop the offending drug.
A choice that recommends starting IV antibiotics or systemic steroids before discontinuing the suspected culprit drug in SJS/TEN.
The Pediatric vs Adult Distribution Flip
Atopic dermatitis distribution flips with age — face and extensors in infants, flexural surfaces in older children and adults. Misreading the age cue leads to wrong morphology matches (e.g., calling infantile atopic dermatitis 'seborrheic dermatitis' or 'cradle cap' when location and pruritus argue otherwise).
A vignette of a 6-month-old with cheek and extensor eczematous patches paired with a distractor labeling it 'flexural eczema' because the candidate pattern-matched on the word 'eczema' alone.
How it works
Treat the vignette as a sieve. First, lock down morphology — a tense bulla is not a flaccid bulla, and a plaque with silvery scale is not a greasy yellow scale. Second, place it in the right map: extensor plus silvery scale points to psoriasis, flexural plus pruritus points to atopic dermatitis, photodistributed plus malar plus joint complaints points to lupus rather than rosacea. Third, snap to the defining clue: Auspitz sign forces psoriasis, Nikolsky-positive flaccid bullae force pemphigus vulgaris, herald patch forces pityriasis rosea, target lesions on palms and soles force erythema multiforme. If a vignette describes a 35-year-old with pink scaly plaques on elbows and knees plus pitted nails, the diagnosis is psoriasis before you finish reading — the only remaining work is whether the stem asks for the underlying immunology (Th17/IL-17 axis), the topical first line (high-potency steroid plus vitamin D analog), or the systemic option for severe disease (anti-TNF, anti-IL-17, methotrexate). Distractors are usually the close mimic (eczema for psoriasis, tinea for nummular eczema, seborrheic dermatitis for scalp psoriasis), so you must explicitly name what was in the stem that the close mimic would not produce.
Worked examples
Which of the following best describes the underlying immunologic mechanism of this patient's condition?
- A IgE-mediated mast cell degranulation against environmental allergens
- B Th17-driven keratinocyte hyperproliferation with IL-17 and IL-23 signaling ✓ Correct
- C IgG autoantibodies against desmoglein 1 and 3
- D Type IV hypersensitivity reaction to a contact allergen
Why B is correct: The combination of well-demarcated silvery-scaled plaques on extensor surfaces, gluteal cleft involvement, nail pitting and oil spots, and a positive Auspitz sign locks the diagnosis as plaque psoriasis. Psoriasis is driven by a Th17 axis with IL-17 and IL-23 producing keratinocyte hyperproliferation and neutrophil recruitment into the epidermis (Munro microabscesses). This is also why anti–IL-17 (secukinumab) and anti–IL-23 (guselkumab) biologics are highly effective.
Why each wrong choice fails:
- A: IgE-mediated mast cell degranulation describes immediate (Type I) hypersensitivity such as urticaria or atopic disease flares — it does not produce silvery-scaled plaques with the Auspitz sign or nail pitting. (The Close-Mimic Differential)
- C: Anti–desmoglein 1 and 3 antibodies cause pemphigus vulgaris, which presents with flaccid bullae, mucosal erosions, and a positive Nikolsky sign — none of which appear in this scaly-plaque vignette. (The Close-Mimic Differential)
- D: Type IV hypersensitivity to a contact allergen produces geometric, often vesicular dermatitis at the contact site, not symmetric extensor plaques with silvery scale and nail changes. (The Close-Mimic Differential)
What is the most appropriate next step in management?
- A Begin high-dose intravenous methylprednisolone and continue allopurinol
- B Discontinue allopurinol and transfer the patient to a burn unit for supportive care ✓ Correct
- C Start oral acyclovir empirically for suspected disseminated herpes simplex virus
- D Apply high-potency topical clobetasol to all affected skin areas
Why B is correct: Mucosal involvement, flaccid bullae with positive Nikolsky sign, recent allopurinol exposure, and 8% body surface area involvement fit Stevens-Johnson syndrome (SJS, defined as <10% BSA). The single most important first step is stopping the offending drug — earlier discontinuation correlates directly with mortality reduction. These patients are managed like burn victims with aggressive fluid resuscitation, wound care, and infection prevention in a specialized unit.
Why each wrong choice fails:
- A: Continuing allopurinol misses the central principle of SJS/TEN management — drug withdrawal is the single intervention with the strongest mortality benefit. Systemic corticosteroid use is also controversial in SJS/TEN, but the dominant error here is failing to stop the culprit drug. (The Drug-Reaction Bait)
- C: Disseminated HSV typically produces grouped vesicles on an erythematous base in patients with eczema (eczema herpeticum) or immunocompromise, not large denuded mucocutaneous sheets after a new sulfa-like drug exposure. The vignette's drug timing and Nikolsky-positive sloughing point clearly to SJS. (The Close-Mimic Differential)
- D: Topical steroid does not address the systemic, drug-driven immunologic injury of SJS/TEN, and crucially it ignores the urgent need to stop allopurinol and transfer to specialized supportive care. (Wrong Treatment for the Right Disease)
Which of the following is the most appropriate management?
- A Reassurance and observation; the eruption is self-limited ✓ Correct
- B Two weeks of oral terbinafine
- C Single-dose intramuscular benzathine penicillin G
- D Two weeks of topical clobetasol propionate to all lesions
Why A is correct: The herald patch followed 1–2 weeks later by a generalized eruption of oval, salmon-colored, scaly lesions on the trunk in a Christmas-tree distribution along skin tension lines is classic pityriasis rosea, associated with HHV-6/7 reactivation. It is self-limited, typically resolving over 6–8 weeks without specific therapy. Reassurance with optional symptomatic antipruritic treatment is appropriate.
Why each wrong choice fails:
- B: Oral terbinafine treats dermatophyte infection, but the negative KOH and the herald-patch-plus-Christmas-tree distribution do not fit tinea — tinea corporis lacks the herald patch and follows no tension-line pattern. (The Close-Mimic Differential)
- C: Secondary syphilis can mimic pityriasis rosea and classically involves palms and soles, but the non-reactive RPR and sparing of palms and soles in this vignette argue against syphilis. The trap is treating before serology supports the diagnosis. (The Close-Mimic Differential)
- D: High-potency topical steroid over the entire trunk for a benign self-limited eruption is overtreatment and risks atrophy and HPA axis suppression. The condition resolves spontaneously and does not require potent steroids. (Wrong Treatment for the Right Disease)
Memory aid
For scaly plaques use SAGE: Silver scale = psoriasis, Annular with central clearing = tinea, Greasy yellow = seborrheic dermatitis, Eczema = ill-defined and itchy in flexures. For blisters use TFNN: Tense + Negative Nikolsky = pemphigoid; Flaccid + positive Nikolsky = pemphigus.
Key distinction
Pemphigus vulgaris (flaccid bullae, mucosa involved, Nikolsky positive, anti-desmoglein, suprabasal split) vs bullous pemphigoid (tense bullae, mucosa typically spared, Nikolsky negative, anti-hemidesmosome, subepidermal split) — this is the most-tested blistering pair on Step 1 and Step 2 CK.
Summary
Match morphology, distribution, and one defining clue; the diagnosis is then forced and the question becomes about mechanism or next step.
Practice common dermatologic conditions adaptively
Reading the rule is the start. Working USMLE Step 1 & 2-format questions on this sub-topic with adaptive selection, watching your mastery score climb in real time, and seeing the items you missed return on a spaced-repetition schedule — that's where score lift actually happens. Free for seven days. No credit card required.
Start your free 7-day trialFrequently asked questions
What is common dermatologic conditions on the USMLE Step 1 & 2?
Most USMLE dermatology items are solved by matching three features: lesion morphology (macule, papule, plaque, vesicle, pustule, nodule), distribution (extensor vs flexural, photodistributed, dermatomal, intertriginous), and a single defining clue (Auspitz sign, Nikolsky sign, herald patch, target lesion, honey crust). When morphology + distribution + clue line up, the diagnosis is forced and the question collapses to either mechanism or next-best-step. Treat the answer choices as a differential of close mimics and eliminate based on the clue the vignette emphasized.
How do I practice common dermatologic conditions questions?
The fastest way to improve on common dermatologic conditions is targeted, adaptive practice — working questions that focus on your specific weak spots within this sub-topic, getting immediate feedback, and revisiting items you missed on a spaced-repetition schedule. Neureto's adaptive engine does this automatically across the USMLE Step 1 & 2; start a free 7-day trial to see your sub-topic mastery climb in real time.
What's the most important distinction to remember for common dermatologic conditions?
Pemphigus vulgaris (flaccid bullae, mucosa involved, Nikolsky positive, anti-desmoglein, suprabasal split) vs bullous pemphigoid (tense bullae, mucosa typically spared, Nikolsky negative, anti-hemidesmosome, subepidermal split) — this is the most-tested blistering pair on Step 1 and Step 2 CK.
Is there a memory aid for common dermatologic conditions questions?
For scaly plaques use SAGE: Silver scale = psoriasis, Annular with central clearing = tinea, Greasy yellow = seborrheic dermatitis, Eczema = ill-defined and itchy in flexures. For blisters use TFNN: Tense + Negative Nikolsky = pemphigoid; Flaccid + positive Nikolsky = pemphigus.
What's a common trap on common dermatologic conditions questions?
Conflating Nikolsky-positive pemphigus vulgaris with Nikolsky-negative bullous pemphigoid
What's a common trap on common dermatologic conditions questions?
Treating tinea with topical steroid (tinea incognito) instead of antifungal
Ready to drill these patterns?
Take a free USMLE Step 1 & 2 assessment — about 25 minutes and Neureto will route more common dermatologic conditions questions your way until your sub-topic mastery score reflects real improvement, not luck. Free for seven days. No credit card required.
Start your free 7-day trial